Sulfamethoxazole + Trimethoprim Suspension Generics - Manufacturers & Suppliers
Bactrim(US)
| Product/Composition:- | Sulfamethoxazole + Trimethoprim Suspension |
|---|---|
| Strength:- | 80 mg/400 mg per 5 mL, 160 mg/800 mg per 5 mL |
| Form:- | Suspension |
| Reference Brands:- | Bactrim(US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Sulfamethoxazole inhibits bacterial folate synthesis, while trimethoprim blocks dihydrofolate reductase, disrupting DNA and protein production. The combination provides broad-spectrum activity, effective against urinary, respiratory, and skin infections. Benefits include rapid bacterial clearance, excellent oral absorption, and convenience for pediatric and outpatient treatment when used properly.
Sulfamethoxazole + Trimethoprim suspension is approved in the EU and US for urinary tract, respiratory, and skin infections. In the EU, brands like Bactrim and Septra are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, quality manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for sulfamethoxazole + trimethoprim suspension, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.